Sterling buys CiVentiChem site
UK-based CDMO Sterling Pharma Solutions has acquired CiVentiChem’s US facility at Cary, close to Research Triangle Park in North Carolina.
Merck to spend €1 billion more at Darmstadt
The management and joint works council of Merck KGaA have made a comprehensive agreement about the main site in Darmstadt, Germany, with the stated aim of securing its future viability as a central science and technology hub and further expanding it.
AGC acquires in two fields
Japan’s AGC has completed the acquisition of Malgrat Pharma Chemicals (MPC), a maker of synthetic APIs based in Spain, from Boheringer Ingelheim.
Charles River to buy CiToxLab
Charles River Laboratories (CRL) has agreed to acquire CiToxLab in a €448 million merger that will create the largest player in the early stage CRO space for the pharmaceuticals industry. The deal is expected to close in Q2, subject to labour consultations, regulatory requirements and customary closing conditions.
Olon acquires CapuaBioservices
Italian CDMO and generic API maker Olon has acquired its compatriot CapuaBioservices, which provides
Four become one in Seqens
Pharmaceutical synthesis and speciality ingredients firm Novacap has announced that it is combining all of its CDMO subsidiaries
Almac adds second high-throughout GMP peptide facility
Global CDMO Almac Group has brought online a second high-throughout facility for the GMP manufacture of its NeoPeptides brand of neoantigen-derived peptides
